The effectiveness of the introduction of dietary therapeutic foods in the eradication of <i>Helicobacter pylori</i> in patients with chronic gastritis

Author:

Minushkin O. N.1ORCID,Nikityuk D. B.2,Pilat T. L.3ORCID,Zverkov I. V.1ORCID,Maslovskii L. V.1ORCID,Evsikov А. E.1ORCID,Kuznetsova Yu. G.1ORCID,Inevatova V. S.4ORCID,Klochkova S. V.5ORCID

Affiliation:

1. Central State Medical Academy of Department for Presidential Affairs of the Russian Federation

2. Federal Research Center for Nutrition, Biotechnology and Food Safety

3. Izmerov Research Institute of Occupational Health

4. Aidiklinik LLC

5. Peoples’ Friendship University of Russia named after Patrice Lumumba

Abstract

Introduction. In recent years, a high resistance of H. pylori infection to antibiotics has been recorded both worldwide and in the Russian Federation. This was the basis for introducing diets that increase the sensitivity of H. pylori to antibiotics into eradication schemes.Aim. To evaluate the effect of specialized therapeutic nutrition products LEOVIT GASTRO on the eradication of H. pylori.Materials and methods. Two study groups were formed: the main group – 22 patients and the control group – 20 patients. The groups were randomized from 42 patients suffering from chronic gastritis associated with H. pylori, by random sampling. To assess the tolerability of treatment, in particular, biochemical blood tests were studied.Results. Therapeutic nutrition provides a significant eradication effect against the background of antibiotic therapy. In 92% of patients, a complete absence of H. pylori contamination was detected, and in 8% of patients the degree of contamination was very weak, although initially it was pronounced, while in the control group, a complete absence of H. pylori contamination was detected in 80% of patients. Analysis of the use of specialized food products indicates the possibility of their use in diseases of the gastrointestinal tract associated with H. pylori, as they promote epithelization, healing of the mucosa, reduction and elimination of inflammation, pain, and discomfort in the gastrointestinal tract.Conclusion. Therapeutic dietary nutrition LEOVIT GASTRO is one of the important factors positively influencing the success rate of eradication treatment.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Ivashkin VT, Mayev IV, Lapina TL, Sheptulin AA, Trukhmanov AS, Baranskaya YeK et al. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association.russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55–70. (In Russ.) https://doi.org/10.22416/1382-4376-201828-1-55-70.

2. Mayev IV, Andreyev DN, Bordin DS, Kucheryavy YuA, Kudryavtseva LV, Vyuchnova YeS et al. helicobacter pylori resistance to clarithromycin in the russian federation. Effective Pharmacotherapy. 2020;16(30):16–22. (In Russ.) https://doi.org/10.33978/2307-3586-2020-16-30-16-22.

3. Andreev DN, Maev IV, Kucheryavyy YA. Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years. Terapevticheskii Arkhiv. 2020;92(11):24–30. (In Russ.) Available at: https://ter-arkhiv.ru/0040-3660/article/view/56917.

4. Лазебник ЛБ, Бордин ДС, Дехнич НН, Козлов РС, Тряпышко АА. VII национальные рекомендации по диагностике и лечению заболеваний, ассоциированных с Helicobacter pylori (VII Московские соглашения): методические рекомендации. 2021. 33 с. Режим доступа: https://www.rnmot.ru/public/uploads/RNMOT/clinical/2021/17102021_Проект%20VII%20национальные%20рекомендации%20по%20диагностике%20и%20лечению%20заболеваний%20ассоциированных%20с%20Helicobacter%20pylori.pdf?ysclid=lqgrb96osh686429104.

5. Pilat TL, Minushkin ON, Lazebnik LB, Zverkov IV, Kuznetsova YuG, Khanferyan RA. Features of diet therapy for H. pylori associated diseases of the gastrointestinal tract. Meditsinskiy Sovet. 2022;16(15):46–61. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-15-46-61.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3